FIELD: organic chemistry, pharmacy. SUBSTANCE: invention relates to novel small di- and trivalent inhibitors of selectin of the formula (II) where X is taken among the group including -CN, -(CH2)nCO2H,-(CH2)n, CO-NH-OH, , -OH; Y is -(CH2)f; R1,R2 are taken independently among the group including hydrogen atom, lower alkyl, halogen atom, -OZ, -NO2,-NH2; R3 is taken among the group including hydrogen atom, lower alkyl, hydroxy-lower alkyl, amino-lower alkyl, lower alkyl-carboxylic acid; f = 1-6; n = 0-2; b = 0-2; m = 1-3; Z means lower alkyl, phenyl, or to their pharmaceutically acceptable salts, esters, amides. Invention relates to also pharmaceutical composition based on new compounds and method of inhibition of E-selectin or P-selectin binding with sLex or sLea. EFFECT: new compounds indicated above, improved method of inhibition. 9 cl, 1 tbl, 10 ex
Title | Year | Author | Number |
---|---|---|---|
NEW TETRACYCLIC COMPOUNDS CONTAINING HETEROATOM, USED AS SELECTIVE MODULATORS OF OESTROGEN RECEPTORS | 2003 |
|
RU2331645C2 |
TETRACYCLIC HETEROCOMPOUNDS AS ESTROGEN RECEPTOR MODULATING AGENTS | 2002 |
|
RU2305099C2 |
CONDENSING DICYCLIC NITROGEN CONTAINING HETEROCYCLES, WHICH HAVE DGAT INHIBITING ACTION | 2003 |
|
RU2342388C2 |
N-HYDROXYLUREAS AS ANTI-INFLAMMATORY AGENTS | 1995 |
|
RU2152935C2 |
PRODRUGS OF CONJUGATED BICYCLIC C5aR ANTAGONISTS | 2019 |
|
RU2794327C2 |
CYCLOPROPYLAMIDE DERIVATIVES AS N-HISTAMINE RECEPTOR MODULATORS | 2007 |
|
RU2449989C2 |
HETEROCYCLIC COMPOUND, PHARMACEUTICAL COMPOSITION AND METHOD OF INHIBITION OF 5-LIPOXYGENASE ACTIVITY | 1995 |
|
RU2136666C1 |
DERIVATIVES OF PROPIONIC ACID (VARIANTS), PHARMACEUTICAL COMPOSITION AND METHOD FOR SELECTIVE INHIBITION OF αβ-INTEGRIN BINDING | 2000 |
|
RU2255933C9 |
COMPOUND, PHARMACEUTICAL COMPOSITION | 1999 |
|
RU2237060C2 |
ANTIVIRAL COMPOUNDS | 2010 |
|
RU2541571C2 |
Authors
Dates
2001-04-27—Published
1996-06-26—Filed